SUPPORT for Patients and Communities Reauthorization Act of 2025
Officially: “SUPPORT for Patients and Communities Reauthorization Act of 2025” Read the full text
What it does
Read it in plain language
1Short title; table of contents
This section gives the Act a short title, the SUPPORT for Patients and Communities Reauthorization Act of 2025, and lists the table of contents for the Act's titles and sections.
Show official text
1. Short title; table of contents (a) Short title This Act may be cited as the SUPPORT for Patients and Communities Reauthorization Act of 2025 . (b) Table of contents The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Title I—Prevention Sec. 101. Prenatal and postnatal health. Sec. 102. Monitoring and education regarding infections associated with illicit drug use and other risk factors. Sec. 103. Preventing overdoses of controlled substances. Sec. 104. Support for individuals and families impacted by fetal alcohol spectrum disorder. Sec. 105. Promoting state choice in PDMP systems. Sec. 106. First responder training program. Sec. 107. Donald J. Cohen National Child Traumatic Stress Initiative. Sec. 108. Protecting suicide prevention lifeline from cybersecurity incidents. Sec. 109. Monitoring and reporting of child, youth, and adult trauma. Sec. 110. Bruce’s law. Sec. 111. Guidance on at-home drug disposal systems. Sec. 112. Assessment of opioid drugs and actions. Sec. 113. Grant program for State and Tribal response to opioid use disorders. Title II—Treatment Sec. 201. Residential treatment program for pregnant and postpartum women. Sec. 202. Improving access to addiction medicine providers. Sec. 203. Mental and behavioral health education and training grants. Sec. 204. Loan repayment program for substance use disorder treatment workforce. Sec. 205. Development and dissemination of model training programs for substance use disorder patient records. Sec. 206. Task force on best practices for trauma-informed identification, referral, and support. Sec. 207. Grants to enhance access to substance use disorder treatment. Sec. 208. State guidance related to individuals with serious mental illness and children with serious emotional disturbance. Sec. 209. Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone. Title III—Recovery Sec. 301. Building communities of recovery. Sec. 302. Peer support technical assistance center. Sec. 303. Comprehensive opioid recovery centers. Sec. 304. Youth prevention and recovery. Sec. 305. CAREER Act. Sec. 306. Addressing economic and workforce impacts of the opioid crisis. Title IV—Miscellaneous matters Sec. 401. Delivery of a controlled substance by a pharmacy to a prescribing practitioner. Sec. 402. Required training for prescribers of controlled substances. I Prevention
101Prenatal and postnatal health
This section would change the funding authorized for the prenatal and postnatal health program under section 317L of the Public Health Service Act. Instead of authorizing whatever sum is necessary for fiscal years 2019 through 2023, the law would authorize $4,250,000 for each of fiscal years 2026 through 2030.
Show official text
101. Prenatal and postnatal health Section 317L(d) of the Public Health Service Act ( 42 U.S.C. 247b–13(d) ) is amended by striking such sums as may be necessary for each of the fiscal years 2019 through 2023 and inserting $4,250,000 for each of fiscal years 2026 through 2030 .
102Monitoring and education regarding infections associated with illicit drug use and other risk factors
This section would amend section 317N(d) of the Public Health Service Act, which authorizes funding for the program on monitoring and education regarding infections associated with illicit drug use and other risk factors. It would replace the authorized funding period of fiscal years 2019 through 2023 with fiscal years 2026 through 2030.
Show official text
102. Monitoring and education regarding infections associated with illicit drug use and other risk factors Section 317N(d) of the Public Health Service Act ( 42 U.S.C. 247b–15(d) ) is amended by striking fiscal years 2019 through 2023 and inserting fiscal years 2026 through 2030 .
103Preventing overdoses of controlled substances
This section would amend the overdose prevention and surveillance program under section 392A of the Public Health Service Act. It would broaden several of the program's purposes and activities so they cover overdoses and risks from any substance, not just opioids: a purpose currently limited to opioids would instead cover substances causing overdose, and other listed activities would be expanded to also address the risk factors associated with overdoses, not just the overdoses themselves. It would change a reference to coding overdose data so that it instead reads monitoring and identifying such data. In the subparagraph that already references public health laboratories and drug analogues, it would insert a comma after the existing reference to public health laboratories, and it would insert the words and other emerging substances related after the existing reference to analogues, extending that reference to also cover other emerging substances. It would rewrite the purpose for which grants to states, localities, and Indian Tribes may be used for innovative detection and response projects: grantees could use funds for innovative projects to detect, identify, and rapidly respond to controlled substance misuse, abuse, and overdoses and their associated risk factors, including changes in patterns of controlled substance use, and such projects could include evidence-based strategies such as wastewater surveillance if the strategy is shown to support actionable prevention efforts and is carried out consistent with applicable federal and state privacy laws. Finally, it would reauthorize the program's appropriations, raising the amount from $496,000,000 for each of fiscal years 2019 through 2023 to $505,579,000 for each of fiscal years 2026 through 2030.
Show official text
103. Preventing overdoses of controlled substances (a) In general Section 392A of the Public Health Service Act ( 42 U.S.C. 280b–1 ) is amended— (1) in subsection (a)(2)— (A) in subparagraph (C), by inserting and associated risks before the period at the end; and (B) in subparagraph (D), by striking opioids and inserting substances causing overdose ; and (2) in subsection (b)(2)— (A) in subparagraph (B), by inserting , and associated risk factors, after such overdoses ; (B) in subparagraph (C), by striking coding and inserting monitoring and identifying ; (C) in subparagraph (E)— (i) by inserting a comma after public health laboratories ; and (ii) by inserting and other emerging substances related after analogues ; and (D) in subparagraph (F), by inserting and associated risk factors after overdoses . (b) Additional grants Section 392A(a)(3) of the Public Health Service Act ( 42 U.S.C. 280b–1(a)(3) ) is amended— (1) in the matter preceding subparagraph (A), by striking and Indian Tribes— and inserting and Indian Tribes for the following purposes: ; (2) by amending subparagraph (A) to read as follows: (A) To carry out innovative projects for grantees to detect, identify, and rapidly respond to controlled substance misuse, abuse, and overdoses, and associated risk factors, including changes in patterns of such controlled substance use. Such projects may include the use of innovative, evidence-based strategies for detecting such patterns, such as wastewater surveillance, if proven to support actionable prevention strategies, in a manner consistent with applicable Federal and State privacy laws. ; and (3) in subparagraph (B), by striking for any and inserting For any . (c) Authorization of appropriations Section 392A(e) of the Public Health Service Act ( 42 U.S.C. 280b–1(e) ) is amended by striking $496,000,000 for each of fiscal years 2019 through 2023 and inserting $505,579,000 for each of fiscal years 2026 through 2030 .
104Support for individuals and families impacted by fetal alcohol spectrum disorder
This section would replace Part O of title III of the Public Health Service Act in its entirety with a new fetal alcohol spectrum disorder (FASD) prevention and services program made up of three new sections. New section 399H would direct the Secretary of Health and Human Services to establish or continue a comprehensive FASD education, prevention, identification, intervention, and services delivery program. The program may include public awareness and education activities aimed at health professionals, educators, counselors, and other service providers, at school-age children (including pregnant and high-risk youth), and at the general public, plus strategies to coordinate information and services across agencies that provide social services, health services, education, vocational training, and civil and criminal justice; research on FASD, including developing diagnostic methods and culturally and linguistically appropriate interventions for preventing prenatal alcohol exposure, which may co-occur with exposure to other substances; building state and Tribal capacity to identify, treat, and support people with FASD and their families, including adapting existing programs, expanding screening and diagnostic capacity, developing and evaluating FASD-informed interventions, training professionals, and disseminating information to affected individuals and families; and an applied research program supporting service demonstration projects, clinical studies, and other models providing advocacy, education, vocational training, counseling, and medical and mental health services for people with fetal alcohol spectrum disorder or fetal alcohol effect and their families. The Secretary may award grants, cooperative agreements, and contracts, and provide technical assistance, to states, Indian Tribes or Tribal organizations, local governments, scientific or academic institutions, or nonprofit organizations that submit an application as the Secretary requires; the Secretary may also require applicants to designate a FASD state or Tribal coordinator and to describe an advisory committee that will guide a statewide or Tribal strategic plan for FASD prevention, identification, treatment, and support. The section defines FASD-informed to mean that a support or intervention program uses culturally and linguistically informed, evidence-based or practice-based interventions and resources to improve the quality of life of a person with FASD and their family. New section 399I would direct the Secretary to award grants, contracts, or cooperative agreements to public or nonprofit private entities with demonstrated FASD expertise, to build local, Tribal, state, and nationwide capacity to prevent FASD. Recipients could use the award to develop public education and outreach on the risks of drinking alcohol during pregnancy; act as a clearinghouse for evidence-based FASD prevention and identification resources and best practices; increase awareness of evidence-based screening tools and intervention services, including by improving state, Tribal, and local affiliate capacity; and provide technical assistance to section 399H grant, contract, or cooperative agreement recipients. Entities apply to the Secretary in whatever form and with whatever information the Secretary requires, and may carry out resource development and dissemination, intervention services, and training and technical assistance through subcontracts with other public or private nonprofit entities with demonstrated FASD expertise. New section 399J would authorize $12,500,000 for each of fiscal years 2026 through 2030 to carry out this part. Separately, this section would require the Secretary, no later than four years after enactment and every year after that, to report to the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce on the activities carried out under sections 399H and 399I to advance FASD public education and awareness, describing those activities and how their outcomes are evaluated, and assessing the activities that support individuals with FASD.
Show official text
104. Support for individuals and families impacted by fetal alcohol spectrum disorder (a) In general Part O of title III of the Public Health Service Act ( 42 U.S.C. 280f et seq. ) is amended to read as follows: O Fetal alcohol spectrum disorder prevention and services program 399H. Fetal alcohol spectrum disorders prevention, intervention, and services delivery program (a) In general The Secretary shall establish or continue activities to support a comprehensive fetal alcohol spectrum disorders (referred to in this section as FASD ) education, prevention, identification, intervention, and services delivery program, which may include— (1) an education and public awareness program to support, conduct, and evaluate the effectiveness of— (A) educational programs targeting health professions schools, social and other supportive services, educators and counselors and other service providers in all phases of childhood development, and other relevant service providers, concerning the prevention, identification, and provision of services for infants, children, adolescents and adults with FASD; (B) strategies to educate school-age children, including pregnant and high-risk youth, concerning FASD; (C) public and community awareness programs concerning FASD; and (D) strategies to coordinate information and services across affected community agencies, including agencies providing social services such as foster care, adoption, and social work, agencies providing health services, and agencies involved in education, vocational training and civil and criminal justice; (2) supporting and conducting research on FASD, as appropriate, including to— (A) develop appropriate medical diagnostic methods for identifying FASD; and (B) develop effective culturally and linguistically appropriate evidence-based or evidence-informed interventions and appropriate supports for preventing prenatal alcohol exposure, which may co-occur with exposure to other substances; (3) building State and Tribal capacity for the identification, treatment, and support of individuals with FASD and their families, which may include— (A) utilizing and adapting existing Federal, State, or Tribal programs to include FASD identification and FASD-informed support; (B) developing and expanding screening and diagnostic capacity for FASD; (C) developing, implementing, and evaluating targeted FASD-informed intervention programs for FASD; (D) providing training with respect to FASD for professionals across relevant sectors; and (E) disseminating information about FASD and support services to affected individuals and their families; and (4) an applied research program concerning intervention and prevention to support and conduct service demonstration projects, clinical studies and other research models providing advocacy, educational and vocational training, counseling, medical and mental health, and other supportive services, as well as models that integrate and coordinate such services, that are aimed at the unique challenges facing individuals with fetal alcohol spectrum disorder or fetal alcohol effect and their families. (b) Grants and Technical Assistance (1) In general The Secretary may award grants, cooperative agreements and contracts and provide technical assistance to eligible entities to carry out subsection (a). (2) Eligible entities To be eligible to receive a grant, or enter into a cooperative agreement or contract, under this section, an entity shall— (A) be a State, Indian Tribe or Tribal organization, local government, scientific or academic institution, or nonprofit organization; and (B) prepare and submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require, including a description of the activities that the entity intends to carry out using amounts received under this section. (3) Additional application contents The Secretary may require that an eligible entity include in the application submitted under paragraph (2)(B)— (A) a designation of an individual to serve as a FASD State or Tribal coordinator of activities such eligible entity proposes to carry out through a grant, cooperative agreement, or contract under this section; and (B) a description of an advisory committee the entity will establish to provide guidance for the entity on developing and implementing a statewide or Tribal strategic plan to prevent FASD and provide for the identification, treatment, and support of individuals with FASD and their families. (c) Definition of FASD-Informed For purposes of this section, the term FASD-informed , with respect to support or an intervention program, means that such support or intervention program uses culturally and linguistically informed evidence-based or practice-based interventions and appropriate resources to support an improved quality of life for an individual with FASD and the family of such individual. 399I. Strengthening capacity and education for fetal alcohol spectrum disorders (a) In general The Secretary shall award grants, contracts, or cooperative agreements, as the Secretary determines appropriate, to public or nonprofit private entities with demonstrated expertise in the field of fetal alcohol spectrum disorders (referred to in this section as FASD ). Such awards shall be for the purposes of building local, Tribal, State, and nationwide capacities to prevent the occurrence of FASD by carrying out the programs described in subsection (b). (b) Programs An entity receiving an award under subsection (a) may use such award for the following purposes: (1) Developing and supporting public education and outreach activities to raise public awareness of the risks associated with alcohol consumption during pregnancy. (2) Acting as a clearinghouse for evidence-based resources on FASD prevention, identification, and culturally and linguistically appropriate best practices to help inform systems of care for individuals with FASD across their lifespan. (3) Increasing awareness and understanding of efficacious, evidence-based screening tools and culturally and linguistically appropriate evidence-based intervention services and best practices, which may include improving the capacity for State, Tribal, and local affiliates. (4) Providing technical assistance to recipients of grants, cooperative agreements, or contracts under section 399H, as appropriate. (c) Application To be eligible for a grant, contract, or cooperative agreement under this section, an entity shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require. (d) Subcontracting A public or private nonprofit entity may carry out the following activities required under this section through contracts or cooperative agreements with other public and private nonprofit entities with demonstrated expertise in FASD: (1) Resource development and dissemination. (2) Intervention services. (3) Training and technical assistance. 399J. Authorization of appropriations There are authorized to be appropriated to carry out this part $12,500,000 for each of fiscal years 2026 through 2030. . (b) Report Not later than 4 years after the date of enactment of this Act, and every year thereafter, the Secretary of Health and Human Services shall prepare and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report containing— (1) a review of the activities carried out pursuant to sections 399H and 399I of the Public Health Service Act, as amended, to advance public education and awareness of fetal alcohol spectrum disorders (referred to in this section as FASD ); (2) a description of— (A) the activities carried out pursuant to such sections 399H and 399I to identify, prevent, and treat FASD; and (B) methods used to evaluate the outcomes of such activities; and (3) an assessment of activities carried out pursuant to such sections 399H and 399I to support individuals with FASD.
105Promoting state choice in PDMP systems
This section would add a new provision to section 399O(h) of the Public Health Service Act, the section governing prescription drug monitoring program grants. It would state that nothing in section 399O allows the Secretary to require states to use a specific vendor or a specific interoperability connection, except to the extent needed to align with nationally recognized, consensus-based open standards, such as those under sections 3001 and 3004 of the Public Health Service Act.
Show official text
105. Promoting state choice in PDMP systems Section 399O(h) of the Public Health Service Act ( 42 U.S.C. 280g–3(h) ) is amended by adding at the end the following: (5) Promoting state choice Nothing in this section shall be construed to authorize the Secretary to require States to use a specific vendor or a specific interoperability connection other than to align with nationally recognized, consensus-based open standards, such as in accordance with sections 3001 and 3004. .
106First responder training program
This section would amend the first responder training program under section 546 of the Public Health Service Act. It would broaden the overdose-reversal drugs the program's training and distribution activities can cover: several references limited to drugs approved or cleared by the FDA would instead read approved, cleared, or otherwise legally marketed, and several references limited specifically to opioids or opioid overdose would be broadened to cover overdoses and overdose-reversal drugs generally, including a reference to opioid and heroin that would become opioid, heroin, and other drug, and an opioid overdose reference that would become overdose. It would also reauthorize the program's appropriations, raising the amount from $36,000,000 for each of fiscal years 2019 through 2023 to $57,000,000 for each of fiscal years 2026 through 2030.
Show official text
106. First responder training program Section 546 of the Public Health Service Act ( 42 U.S.C. 290ee–1 ) is amended— (1) in subsection (a), by striking tribes and tribal and inserting Tribes and Tribal ; (2) in subsections (a), (c), and (d)— (A) by striking approved or cleared each place it appears and inserting approved, cleared, or otherwise legally marketed ; and (B) by striking opioid each place it appears; (3) in subsection (f)— (A) by striking approved or cleared each place it appears and inserting approved, cleared, or otherwise legally marketed ; (B) in paragraph (1), by striking opioid ; (C) in paragraph (2)— (i) by striking opioid and heroin and inserting opioid, heroin, and other drug ; and (ii) by striking opioid overdose and inserting overdose ; and (D) in paragraph (3), by striking opioid and heroin ; and (4) in subsection (h), by striking $36,000,000 for each of fiscal years 2019 through 2023 and inserting $57,000,000 for each of fiscal years 2026 through 2030 .
107Donald J. Cohen National Child Traumatic Stress Initiative
This section would first make a technical fix to the Public Health Service Act: a part G that had been added twice to title V, once by the Community Renewal Tax Relief Act, would be redesignated as part J, and its sections 581 through 584 would be redesignated as sections 596 through 596C, with no change to their substance. It would then amend section 582, the National Child Traumatic Stress Initiative (NCTSI). The section heading would change from violence related stress to traumatic events, broadening the initiative's stated subject matter. Wherever subsections (a) and (b) describe developing evidence-based practices and services, the section would add and dissemination, so the program covers disseminating those practices, not only developing them. Subsection (d) would be split into a coordinating center paragraph restating the existing NCTSI role, and a new NCTSI grantees paragraph under which NCTSI grantees must develop trainings and other resources, as applicable and appropriate, to support implementation of the evidence-based practices developed and disseminated under subsection (a)(2). Subsection (e) would similarly add and implementation to the coordinating center's dissemination-related duty, and add a new NCTSI grantees paragraph requiring grantees to collaborate, as appropriate, with other grantees, the NCTSI coordinating center, and the Secretary in carrying out subsections (a)(2) and (d)(2). The section would rewrite the application and evaluation requirements in subsection (h): to be eligible for a grant, contract, or cooperative agreement, a public or nonprofit private entity or an Indian Tribe or Tribal organization must submit an application that includes a plan to evaluate the funded activities, covering both process and outcomes, with an evaluation submitted at the end of the project period, and a description of how the applicant will support Secretary-led or NCTSI coordinating center-led efforts to evaluate activities under the section. Finally, it would rewrite the authorization of appropriations in subsection (j) to set the amount at $98,887,000 for each of fiscal years 2026, 2027, and 2028, and $100,000,000 for each of fiscal years 2029 and 2030.
Show official text
107. Donald J. Cohen National Child Traumatic Stress Initiative (a) Technical amendment The second part G of title V of the Public Health Service Act ( 42 U.S.C. 290kk et seq. ), as added by section 144 of the Community Renewal Tax Relief Act ( Public Law 106–554 ), is amended— (1) by redesignating such part as part J; and (2) by redesignating sections 581 through 584 as sections 596 through 596C, respectively. (b) In general Section 582 of the Public Health Service Act ( 42 U.S.C. 290hh–1 ) is amended— (1) in the section heading, by striking VIOLENCE RELATED STRESS and inserting TRAUMATIC EVENTS ; (2) in subsection (a)— (A) in the matter preceding paragraph (1), by striking tribes and tribal and inserting Tribes and Tribal ; and (B) in paragraph (2), by inserting and dissemination after the development ; (3) in subsection (b), by inserting and dissemination after the development ; (4) in subsection (d)— (A) by striking The NCTSI and inserting the following: (1) Coordinating center The NCTSI ; and (B) by adding at the end the following: (2) NCTSI grantees In carrying out subsection (a)(2), NCTSI grantees shall develop trainings and other resources, as applicable and appropriate, to support implementation of the evidence-based practices developed and disseminated under such subsection. ; (5) in subsection (e)— (A) by redesignating paragraphs (1) and (2) as subparagraphs (A) and (B), respectively, and adjusting the margins accordingly; (B) in subparagraph (A), as so redesignated, by inserting and implementation after the dissemination ; (C) by striking The NCTSI and inserting the following: (1) Coordinating center The NCTSI ; and (D) by adding at the end the following: (2) NCTSI grantees NCTSI grantees shall, as appropriate, collaborate with other such grantees, the NCTSI coordinating center, and the Secretary in carrying out subsections (a)(2) and (d)(2). ; (6) by amending subsection (h) to read as follows: (h) Application and evaluation To be eligible to receive a grant, contract, or cooperative agreement under subsection (a), a public or nonprofit private entity or an Indian Tribe or Tribal organization shall submit to the Secretary an application at such time, in such manner, and containing such information and assurances as the Secretary may require, including— (1) a plan for the evaluation of the activities funded under the grant, contract, or agreement, including both process and outcomes evaluation, and the submission of an evaluation at the end of the project period; and (2) a description of how such entity, Indian Tribe, or Tribal organization will support efforts led by the Secretary or the NCTSI coordinating center, as applicable, to evaluate activities carried out under this section. ; and (7) by amending subsection (j) to read as follows: (j) Authorization of appropriations There is authorized to be appropriated to carry out this section— (1) $98,887,000 for fiscal year 2026; (2) $98,887,000 for fiscal year 2027; (3) $98,887,000 for fiscal year 2028; (4) $100,000,000 for fiscal year 2029; and (5) $100,000,000 for fiscal year 2030. .
108Protecting suicide prevention lifeline from cybersecurity incidents
This section would amend the 988 National Suicide Prevention Lifeline program under section 520E-3 of the Public Health Service Act. It would add a new required activity under subsection (b): taking steps necessary to protect the suicide prevention hotline from cybersecurity incidents and to eliminate known cybersecurity vulnerabilities. It would also add a new subsection (f) on cybersecurity reporting. The program's network administrator that receives federal funding must report any identified cybersecurity vulnerability or incident affecting the program to the Assistant Secretary within a reasonable time after identifying it, in a manner that protects personal privacy consistent with applicable federal and state privacy laws. Local and regional crisis centers participating in the program must likewise report identified vulnerabilities or incidents to the network administrator within a reasonable time, and if the network administrator discovers a vulnerability or incident itself, or is informed of one by a crisis center, the network administrator must report it to the Assistant Secretary within a reasonable time. Local and regional crisis centers must oversee all the technology they use to provide services under the program, except that the network administrator must oversee a crisis center's technology if the network participation agreement makes the administrator responsible for that oversight. These cybersecurity reporting requirements would supplement, not replace, any other federal cybersecurity incident reporting requirements already in effect when this Act is enacted. Finally, this section would require the Comptroller General, no later than 180 days after enactment, to complete a study evaluating cybersecurity risks and vulnerabilities associated with the 988 National Suicide Prevention Lifeline and to report the findings to the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce.
Show official text
108. Protecting suicide prevention lifeline from cybersecurity incidents (a) National suicide prevention lifeline program Section 520E–3(b) of the Public Health Service Act (42 U.S.C. 290bb–36c(b)) is amended— (1) in paragraph (4), by striking and at the end; (2) in paragraph (5), by striking the period at the end and inserting ; and ; and (3) by adding at the end the following: (6) taking such steps as may be necessary to ensure the suicide prevention hotline is protected from cybersecurity incidents and eliminates known cybersecurity vulnerabilities. . (b) Reporting Section 520E–3 of the Public Health Service Act ( 42 U.S.C. 290bb–36c ) is amended— (1) by redesignating subsection (f) as subsection (g); and (2) by inserting after subsection (e) the following: (f) Cybersecurity reporting (1) Notification (A) In general The program’s network administrator receiving Federal funding pursuant to subsection (a) shall report to the Assistant Secretary, in a manner that protects personal privacy, consistent with applicable Federal and State privacy laws— (i) any identified cybersecurity vulnerabilities to the program within a reasonable amount of time after identification of such a vulnerability; and (ii) any identified cybersecurity incidents to the program within a reasonable amount of time after identification of such incident. (B) Local and regional crisis centers Local and regional crisis centers participating in the program shall report to the program’s network administrator identified under subparagraph (A), in a manner that protects personal privacy, consistent with applicable Federal and State privacy laws— (i) any identified cybersecurity vulnerabilities to the program within a reasonable amount of time after identification of such vulnerability; and (ii) any identified cybersecurity incidents to the program within a reasonable amount of time after identification of such incident. (2) Notification If the program’s network administrator receiving funding pursuant to subsection (a) discovers, or is informed by a local or regional crisis center pursuant to paragraph (1)(B) of, a cybersecurity vulnerability or incident, within a reasonable amount of time after such discovery or receipt of information, such entity shall report the vulnerability or incident to the Assistant Secretary. (3) Clarification (A) Oversight (i) Local and regional crisis centers Except as provided in clause (ii), local and regional crisis centers participating in the program shall oversee all technology each center employs in the provision of services as a participant in the program. (ii) Network administrator The program’s network administrator receiving Federal funding pursuant to subsection (a) shall oversee the technology each crisis center employs in the provision of services as a participant in the program if such oversight responsibilities are established in the applicable network participation agreement. (B) Supplement, not supplant The cybersecurity incident reporting requirements under this subsection shall supplement, and not supplant, cybersecurity incident reporting requirements under other provisions of applicable Federal law that are in effect on the date of the enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025 . . (c) Study Not later than 180 days after the date of the enactment of this Act, the Comptroller General of the United States shall— (1) conduct and complete a study that evaluates cybersecurity risks and vulnerabilities associated with the 9–8–8 National Suicide Prevention Lifeline; and (2) submit a report on the findings of such study to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives.
109Monitoring and reporting of child, youth, and adult trauma
This section would reauthorize the child, youth, and adult trauma monitoring and reporting program under section 7131(e) of the SUPPORT for Patients and Communities Act, raising the authorized funding from $2,000,000 for each of fiscal years 2019 through 2023 to $9,000,000 for each of fiscal years 2026 through 2030.
Show official text
109. Monitoring and reporting of child, youth, and adult trauma Section 7131(e) of the SUPPORT for Patients and Communities Act ( 42 U.S.C. 242t(e) ) is amended by striking $2,000,000 for each of fiscal years 2019 through 2023 and inserting $9,000,000 for each of fiscal years 2026 through 2030 .
110Bruce's law
This section, known as Bruce's law, would amend two parts of the SUPPORT for Patients and Communities Act. First, it would amend the youth prevention and recovery grant program under section 7102(c). It would let grantee strategies for reaching at-risk populations, under paragraph (3)(A)(i), and grantee activities under paragraph (4)(A) include increasing education and awareness of the potency and dangers of synthetic opioids, including drugs contaminated with fentanyl, and, as appropriate, other emerging drug use or misuse issues. Second, it would amend the Interdepartmental Substance Use Disorders Coordinating Committee under section 7022. It would rewrite subsection (g) to state that the Committee may establish working groups, made up of Committee members or their designees, to carry out the Committee's duties, and that such a working group may meet as necessary. It would also require the Secretary, acting through the Committee, to establish a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, made up of representatives from relevant federal departments and agencies on the Committee. The Work Group must consult with state, Tribal, and local subject matter experts on reducing, preventing, and responding to fentanyl-contaminated drug overdoses, and with family members of adults and youth who have overdosed on fentanyl-contaminated illicit drugs. The Work Group must examine federal efforts to reduce and prevent overdoses from fentanyl-contaminated drugs; identify strategies to improve state, Tribal, and local responses; coordinate with the Secretary on public awareness activities about synthetic opioids and other emerging drug issues; make recommendations to Congress for improving federal programs and their coordination; and make recommendations for educating youth about the dangers of fentanyl-contaminated drugs. The Work Group must submit an annual report to the Secretary, the Senate Committee on Health, Education, Labor, and Pensions, and the House Committees on Energy and Commerce and Education and Workforce, on its activities and recommendations to reduce and prevent fentanyl-related overdoses across all populations and specifically among at-risk youth. This section would also replace the Committee's sunset date: the Committee would terminate on September 30, 2030.
Show official text
110. Bruce’s law (a) Youth prevention and recovery Section 7102(c) of the SUPPORT for Patients and Communities Act (42 U.S.C. 290bb–7a(c)) is amended— (1) in paragraph (3)(A)(i), by inserting , which may include strategies to increase education and awareness of the potency and dangers of synthetic opioids (including drugs contaminated with fentanyl) and, as appropriate, other emerging drug use or misuse issues before the semicolon; and (2) in paragraph (4)(A), by inserting and strategies to increase education and awareness of the potency and dangers of synthetic opioids (including drugs contaminated with fentanyl) and, as appropriate, emerging drug use or misuse issues before the semicolon. (b) Interdepartmental substance use disorders coordinating committee Section 7022 of the SUPPORT for Patients and Communities Act ( 42 U.S.C. 290aa note) is amended— (1) by striking subsection (g) and inserting the following: (g) Working groups (1) In general The Committee may establish working groups for purposes of carrying out the duties described in subsection (e). Any such working group shall be composed of members of the Committee (or the designees of such members) and may hold such meetings as are necessary to carry out the duties delegated to the working group. (2) Additional federal interagency work group on fentanyl contamination of illegal drugs (A) Establishment The Secretary, acting through the Committee, shall establish a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs (referred to in this paragraph as the Work Group ) consisting of representatives from relevant Federal departments and agencies on the Committee. (B) Consultation The Work Group shall consult with relevant stakeholders and subject matter experts, including— (i) State, Tribal, and local subject matter experts in reducing, preventing, and responding to drug overdose caused by fentanyl contamination of illicit drugs; and (ii) family members of both adults and youth who have overdosed by fentanyl contaminated illicit drugs. (C) Duties The Work Group shall— (i) examine Federal efforts to reduce and prevent drug overdose by fentanyl-contaminated illicit drugs; (ii) identify strategies to improve State, Tribal, and local responses to overdose by fentanyl-contaminated illicit drugs; (iii) coordinate with the Secretary, as appropriate, in carrying out activities to raise public awareness of synthetic opioids and other emerging drug use and misuse issues; (iv) make recommendations to Congress for improving Federal programs, including with respect to the coordination of efforts across such programs; and (v) make recommendations for educating youth on the potency and dangers of drugs contaminated by fentanyl. (D) Annual report to secretary The Work Group shall annually prepare and submit to the Secretary, the Committee on Health, Education, Labor, and Pensions of the Senate, and the Committee on Energy and Commerce and the Committee on Education and Workforce of the House of Representatives, a report on the activities carried out by the Work Group under subparagraph (C), including recommendations to reduce and prevent drug overdose by fentanyl contamination of illegal drugs, in all populations, and specifically among youth at risk for substance misuse. ; and (2) by striking subsection (i) and inserting the following: (i) Sunset The Committee shall terminate on September 30, 2030. .
111Guidance on at-home drug disposal systems
This section would require the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration and no later than one year after enactment, to publish guidance to facilitate the use of at-home safe disposal systems for applicable drugs. The guidance must include recommended standards for effective at-home drug disposal systems that meet FDA-enforced requirements, recommended information to include as instructions for use, best practices and educational tools to support use of such systems as appropriate, and recommended use of licensed health providers to disseminate education, instructions, and the disposal systems themselves, as appropriate.
Show official text
111. Guidance on at-home drug disposal systems (a) In general Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, shall publish guidance to facilitate the use of at-home safe disposal systems for applicable drugs. (b) Contents The guidance under subsection (a) shall include— (1) recommended standards for effective at-home drug disposal systems to meet applicable requirements enforced by the Food and Drug Administration; (2) recommended information to include as instructions for use to disseminate with at-home drug disposal systems; (3) best practices and educational tools to support the use of an at-home drug disposal system, as appropriate; and (4) recommended use of licensed health providers for the dissemination of education, instruction, and at-home drug disposal systems, as appropriate.
112Assessment of opioid drugs and actions
This section would require the Secretary of Health and Human Services, no later than one year after enactment, to publish on the FDA's website a report outlining a plan for assessing FDA-approved opioid analgesic drugs, addressing the public health effects of those drugs as part of the FDA's benefit-risk assessment, and the FDA's work to facilitate development of nonaddictive medical products to treat pain or addiction. The report must include an update on FDA actions considering the effectiveness, safety, benefit-risk profile, and use of approved opioid analgesics; a timeline for assessing whether labeling changes, revised or additional postmarketing requirements, enforcement actions, or withdrawals may be needed for such drugs; an overview of FDA steps to support development and approval of nonaddictive pain or addiction treatment products and planned further steps; and an overview of the FDA's consideration of clinical trial methodologies for analgesic drugs, including the enriched enrollment randomized withdrawal methodology, and the benefits and drawbacks of different methodologies, incorporating public input received under subsection (b). Under subsection (b), the Secretary must provide an opportunity for public input on the FDA's regulation of opioid analgesic drugs, including scientific evidence on their conditions of use, safety, and benefit-risk assessment.
Show official text
112. Assessment of opioid drugs and actions (a) In general Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the Secretary ) shall publish on the website of the Food and Drug Administration (referred to in this section as the FDA ) a report that outlines a plan for assessing opioid analgesic drugs that are approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) that addresses the public health effects of such opioid analgesic drugs as part of the benefit-risk assessment and the activities of the FDA that relate to facilitating the development of nonaddictive medical products intended to treat pain or addiction. Such report shall include— (1) an update on the actions taken by the FDA to consider the effectiveness, safety, benefit-risk profile, and use of approved opioid analgesic drugs; (2) a timeline for an assessment of the potential need, as appropriate, for labeling changes, revised or additional postmarketing requirements, enforcement actions, or withdrawals for opioid analgesic drugs; (3) an overview of the steps that the FDA has taken to support the development and approval of nonaddictive medical products intended to treat pain or addiction, and actions planned to further support the development and approval of such products; and (4) an overview of the consideration by the FDA of clinical trial methodologies for analgesic drugs, including the enriched enrollment randomized withdrawal methodology, and the benefits and drawbacks associated with different trial methodologies for such drugs, incorporating any public input received under subsection (b). (b) Public input In carrying out subsection (a), the Secretary shall provide an opportunity for public input concerning the regulation by the FDA of opioid analgesic drugs, including scientific evidence that relates to conditions of use, safety, or benefit-risk assessment (including consideration of the public health effects) of such opioid analgesic drugs.
113Grant program for State and Tribal response to opioid use disorders
This section would allow activities carried out under section 1003(b)(4)(A) of the 21st Century Cures Act, a state and Tribal opioid response grant program, to include facilitating access to products that help prevent overdose deaths by detecting the presence of one or more substances, such as fentanyl and xylazine test strips, to the extent that purchasing and possessing such products is consistent with federal and state law.
Show official text
113. Grant program for State and Tribal response to opioid use disorders The activities carried out pursuant to section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) may include facilitating access to products used to prevent overdose deaths by detecting the presence of one or more substances, such as fentanyl and xylazine test strips, to the extent the purchase and possession of such products is consistent with Federal and State law. II Treatment
201Residential treatment program for pregnant and postpartum women
This section would amend the residential treatment program for pregnant and postpartum women under section 508 of the Public Health Service Act. A reference to providing health services in subsection (d)(11)(C) would be changed to providing health care services. Under subsection (g), an applicant that currently must state it will provide certain services would instead have to provide a plan describing how it will do so, and that plan may include a description of how the applicant will target outreach to women disproportionately affected by maternal substance use disorder. The section would also reauthorize the program's appropriations, raising the amount from $29,931,000 for each of fiscal years 2019 through 2023 to $38,931,000 for each of fiscal years 2026 through 2030.
Show official text
201. Residential treatment program for pregnant and postpartum women Section 508 of the Public Health Service Act ( 42 U.S.C. 290bb–1 ) is amended— (1) in subsection (d)(11)(C), by striking providing health services and inserting providing health care services ; (2) in subsection (g)— (A) by inserting a plan describing after will provide ; and (B) by adding at the end the following: Such plan may include a description of how such applicant will target outreach to women disproportionately impacted by maternal substance use disorder. ; and (3) in subsection (s), by striking $29,931,000 for each of fiscal years 2019 through 2023 and inserting $38,931,000 for each of fiscal years 2026 through 2030 .
202Improving access to addiction medicine providers
This section would amend section 597 of the Public Health Service Act. It would add diagnosis to the activities described in subsection (a)(1), and it would add addiction medicine alongside psychiatry in the list of fields covered by subsection (b).
Show official text
202. Improving access to addiction medicine providers Section 597 of the Public Health Service Act ( 42 U.S.C. 290ll ) is amended— (1) in subsection (a)(1), by inserting diagnosis, after related to ; and (2) in subsection (b), by inserting addiction medicine, after psychiatry, .
203Mental and behavioral health education and training grants
This section would extend the authorization period for mental and behavioral health education and training grants under section 756(f) of the Public Health Service Act from fiscal years 2023 through 2027 to fiscal years 2026 through 2030.
Show official text
203. Mental and behavioral health education and training grants Section 756(f) of the Public Health Service Act ( 42 U.S.C. 294e–1(f) ) is amended by striking fiscal years 2023 through 2027 and inserting fiscal years 2026 through 2030 .
204Loan repayment program for substance use disorder treatment workforce
This section would reauthorize the substance use disorder treatment workforce loan repayment program under section 781(j) of the Public Health Service Act, raising the authorized funding from $25,000,000 for each of fiscal years 2019 through 2023 to $40,000,000 for each of fiscal years 2026 through 2030.
Show official text
204. Loan repayment program for substance use disorder treatment workforce Section 781(j) of the Public Health Service Act ( 42 U.S.C. 295h(j) ) is amended by striking $25,000,000 for each of fiscal years 2019 through 2023 and inserting $40,000,000 for each of fiscal years 2026 through 2030 .
205Development and dissemination of model training programs for substance use disorder patient records
Show official text
205. Development and dissemination of model training programs for substance use disorder patient records Section 7053 of the SUPPORT for Patients and Communities Act ( 42 U.S.C. 290dd–2 note) is amended by striking subsection (e).
206Task force on best practices for trauma-informed identification, referral, and support
This section would amend the task force on best practices for trauma-informed identification, referral, and support under section 7132 of the SUPPORT for Patients and Communities Act. It would add the Administration for Community Living as a member of the task force under subsection (b)(1). It would add developmental disability service providers to the group of parties addressed in subsection (d)(1), alongside the individuals already listed there. And it would extend the task force's authorization, replacing a 2023 date in subsection (i) with 2030.
Show official text
206. Task force on best practices for trauma-informed identification, referral, and support Section 7132 of the SUPPORT for Patients and Communities Act ( Public Law 115–271 ; 132 Stat. 4046) is amended— (1) in subsection (b)(1)— (A) by redesignating subparagraph (CC) as subparagraph (DD); and (B) by inserting after subparagraph (BB) the following: (CC) The Administration for Community Living. ; (2) in subsection (d)(1), in the matter preceding subparagraph (A), by inserting , developmental disability service providers before , individuals who are ; and (3) in subsection (i), by striking 2023 and inserting 2030 .
207Grants to enhance access to substance use disorder treatment
Show official text
207. Grants to enhance access to substance use disorder treatment Section 3203 of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 823 note) is amended— (1) by striking subsection (b); and (2) by striking (a) In general .—The Secretary and inserting the following: The Secretary .
208State guidance related to individuals with serious mental illness and children with serious emotional disturbance
This section would require the Secretary of Health and Human Services, acting through the Assistant Secretary for Mental Health and Substance Use and no later than one year after enactment, to review how states use Community Mental Health Services Block Grant funds for first episode psychosis activities. The review must consider how states use funds for evidence-based treatments and services that meet the standard of care for people with early serious mental illness and children with serious emotional disturbance, and what percentage of block grant funding states spend on early serious mental illness and first episode psychosis, and how many individuals are served with those funds. No later than 180 days after completing the review, the Secretary must report the review's findings and any recommendations for changes to the block grant program to the Senate Committees on Health, Education, Labor, and Pensions and on Appropriations and the House Committees on Energy and Commerce and on Appropriations. No later than one year after submitting that report, the Secretary must update the guidance provided to states on coordinated specialty care and other evidence-based mental health services for people with serious mental illness and children with serious emotional disturbance, based on the report's findings and recommendations.
Show official text
208. State guidance related to individuals with serious mental illness and children with serious emotional disturbance (a) Review of use of certain funding Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the Secretary ), acting through the Assistant Secretary for Mental Health and Substance Use, shall conduct a review of State use of funds made available under the Community Mental Health Services Block Grant program under subpart I of part B of title XIX of the Public Health Service Act ( 42 U.S.C. 300x et seq. ) (referred to in this section as the block grant program ) for first episode psychosis activities. Such review shall consider the following: (1) How States use funds for evidence-based treatments and services according to the standard of care for individuals with early serious mental illness and children with a serious emotional disturbance. (2) The percentages of the State funding under the block grant program expended on early serious mental illness and first episode psychosis, and the number of individuals served under such funds. (b) Report and guidance (1) Report Not later than 180 days after the completion of the review under subsection (a), the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives a report describing— (A) the findings of the review under subsection (a); and (B) any recommendations for changes to the block grant program that would facilitate improved outcomes for individuals with serious mental illness and children with serious emotional disturbance. (2) Guidance Not later than 1 year after the date on which the report is submitted under paragraph (1), the Secretary shall update the guidance provided to States under the block grant program on coordinated specialty care and other evidence-based mental health care services for individuals with serious mental illness and children with a serious emotional disturbance, based on the findings and recommendations of such report.
209Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone
This section would require the Secretary of Health and Human Services, following the procedures in sections 201 and 202 of the Controlled Substances Act, to review data on the drug schedule status of FDA-approved products that combine buprenorphine and naloxone, and, if appropriate, to ask the Attorney General to start rulemaking to revise the schedule for those products. The Attorney General must review any such request from the Secretary and decide whether to start rulemaking to revise the schedule, applying the criteria in sections 201 and 202 of the Controlled Substances Act.
Show official text
209. Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone (a) Secretary of HHS The Secretary of Health and Human Services shall, consistent with the requirements and procedures set forth in sections 201 and 202 of the Controlled Substances Act ( 21 U.S.C. 811 , 812)— (1) review the relevant data pertaining to the scheduling of products containing a combination of buprenorphine and naloxone that have been approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ); and (2) if appropriate, request that the Attorney General initiate rulemaking proceedings to revise the schedules accordingly with respect to such products. (b) Attorney General The Attorney General shall review any request made by the Secretary of Health and Human Services under subsection (a)(2) and determine whether to initiate proceedings to revise the schedules in accordance with the criteria set forth in sections 201 and 202 of the Controlled Substances Act ( 21 U.S.C. 811 , 812). III Recovery
301Building communities of recovery
This section would reauthorize the building communities of recovery grant program under section 547(f) of the Public Health Service Act, raising the authorized funding from $5,000,000 for each of fiscal years 2019 through 2023 to $17,000,000 for each of fiscal years 2026 through 2030.
Show official text
301. Building communities of recovery Section 547(f) of the Public Health Service Act ( 42 U.S.C. 290ee–2(f) ) is amended by striking $5,000,000 for each of fiscal years 2019 through 2023 and inserting $17,000,000 for each of fiscal years 2026 through 2030 .
302Peer support technical assistance center
This section would amend the peer support technical assistance center program under section 547A of the Public Health Service Act. It would expand the description of capacity building in subsection (b)(4) to give two examples: professional development of peer support specialists, and making recovery support services available in nonclinical settings. It would add a new subsection (d) allowing the Secretary to establish, using existing resources, one regional technical assistance center to help the existing center carry out its activities within that region, tailored to the region's needs. No later than four years after enactment, the Secretary must evaluate the regional center's activities and report the findings to the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce, describing the distinct roles of the regional center and the existing center, available information on the regional center's outcomes, such as its impact on the existing center's operations and efficiency in handling requests for technical assistance within the region, any gaps or duplication between the two centers' activities in the region, and recommendations on whether to modify, expand, or end the regional center. The authority to run a regional center would terminate on September 30, 2030. The section would also reauthorize the program's appropriations, raising the amount from $1,000,000 for each of fiscal years 2019 through 2023 to $2,000,000 for each of fiscal years 2026 through 2030.
Show official text
302. Peer support technical assistance center Section 547A of the Public Health Service Act ( 42 U.S.C. 290ee–2a ) is amended— (1) in subsection (b)(4), by striking building; and and inserting the following: building, such as— (A) professional development of peer support specialists; and (B) making recovery support services available in nonclinical settings; and ; (2) by redesignating subsections (d) and (e) as subsections (e) and (f), respectively; (3) by inserting after subsection (c) the following: (d) Regional centers (1) In general The Secretary may establish one regional technical assistance center (referred to in this subsection as the Regional Center ), with existing resources, to assist the Center in carrying out activities described in subsection (b) within the geographic region of such Regional Center in a manner that is tailored to the needs of such region. (2) Evaluation Not later than 4 years after the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025 , the Secretary shall evaluate the activities of the Regional Center and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the findings of such evaluation, including— (A) a description of the distinct roles and responsibilities of the Regional Center and the Center; (B) available information relating to the outcomes of the Regional Center under this subsection, such as any impact on the operations and efficiency of the Center relating to requests for technical assistance and support within the region of such Regional Center; (C) a description of any gaps or areas of duplication relating to the activities of the Regional Center and the Center within such region; and (D) recommendations relating to the modification, expansion, or termination of the Regional Center under this subsection. (3) Termination This subsection shall terminate on September 30, 2030. ; and (4) in subsection (f), as so redesignated, by striking $1,000,000 for each of fiscal years 2019 through 2023 and inserting $2,000,000 for each of fiscal years 2026 through 2030 .
303Comprehensive opioid recovery centers
This section would amend the comprehensive opioid recovery center program under section 552 of the Public Health Service Act. Under subsection (d)(2), applications would have to include whatever additional information and assurances, including supporting documentation, the Secretary requires, not just be submitted in whatever manner the Secretary requires. It would also change the eligibility standard in subparagraph (A): instead of showing it is capable of coordinating with other entities to carry out certain activities, an applicant would have to show it has the demonstrated capability to carry out those activities itself, through referral or contractual arrangements. It would add a new reporting requirement in subsection (h): an entity that carries out its activities through referral or contractual arrangements must include, in its regular submissions, information on the status of those arrangements, including an assessment of whether they are supporting the entity's ability to carry out its activities. It would also extend the program's authorization of appropriations under subsection (j) from fiscal years 2019 through 2023 to fiscal years 2026 through 2030.
Show official text
303. Comprehensive opioid recovery centers Section 552 of the Public Health Service Act ( 42 U.S.C. 290ee–7 ) is amended— (1) in subsection (d)(2)— (A) in the matter preceding subparagraph (A), by striking and in such manner and inserting , in such manner, and containing such information and assurances, including relevant documentation, ; and (B) in subparagraph (A), by striking is capable of coordinating with other entities to carry out and inserting has the demonstrated capability to carry out, through referral or contractual arrangements ; (2) in subsection (h)— (A) by redesignating paragraphs (1) through (4) as subparagraphs (A) through (D), respectively, and adjusting the margins accordingly; (B) by striking With respect to and inserting the following: (1) In general With respect to ; and (C) by adding at the end the following: (2) Additional reporting for certain eligible entities An entity carrying out activities described in subsection (g) through referral or contractual arrangements shall include in the submissions required under paragraph (1) information related to the status of such referrals or contractual arrangements, including an assessment of whether such referrals or contractual arrangements are supporting the ability of such entity to carry out such activities. ; and (3) in subsection (j), by striking 2019 through 2023 and inserting 2026 through 2030 .
304Youth prevention and recovery
This section would amend the youth prevention and recovery grant program under section 7102(c) of the SUPPORT for Patients and Communities Act. It would make a consortium of local educational agencies eligible alongside a single local educational agency, and it would replace a reference to high schools with the broader term secondary schools. It would define Indian Tribe and Tribal organization by reference to section 4 of the Indian Self-Determination and Education Assistance Act, and it would add a definition of secondary school that adopts the meaning given that term in section 8101 of the Elementary and Secondary Education Act of 1965. It would clarify that the specific populations the program addresses means populations at increased risk for substance misuse, and it would remove references to abuse alongside misuse in the descriptions of populations served and of grantee activities. It would also replace a reference to peer mentoring with the broader term peer-to-peer support. It would add a new required element for grant applicants: a plan to sustain the activities carried out under the grant program after the grant program ends. It would extend a program deadline from 2022 to 2028, and it would rewrite the authorization of appropriations to set the amount at $10,000,000 for fiscal year 2026, $12,000,000 for fiscal year 2027, $13,000,000 for fiscal year 2028, $14,000,000 for fiscal year 2029, and $15,000,000 for fiscal year 2030.
Show official text
304. Youth prevention and recovery Section 7102(c) of the SUPPORT for Patients and Communities Act (42 U.S.C. 290bb–7a(c)) (as amended by section 110(a)) is amended— (1) in paragraph (2)— (A) in subparagraph (A)— (i) in clause (i)— (I) by inserting , or a consortium of local educational agencies, after a local educational agency ; and (II) by striking high schools and inserting secondary schools ; and (ii) in clause (vi), by striking tribe, or tribal and inserting Tribe, or Tribal ; (B) by amending subparagraph (E) to read as follows: (E) Indian tribe; tribal organization The terms Indian Tribe and Tribal organization have the meanings given such terms in section 4 of the Indian Self-Determination and Education Assistance Act ( 25 U.S.C. 5304 ). ; (C) by redesignating subparagraph (K) as subparagraph (L); and (D) by inserting after subparagraph (J) the following: (K) Secondary school The term secondary school has the meaning given such term in section 8101 of the Elementary and Secondary Education Act of 1965 ( 20 U.S.C. 7801 ). ; (2) in paragraph (3)(A), in the matter preceding clause (i)— (A) by striking and abuse ; and (B) by inserting at increased risk for substance misuse after specific populations ; (3) in paragraph (4)— (A) in the matter preceding subparagraph (A), by striking Indian tribes and inserting Indian Tribes ; (B) in subparagraph (A), by striking and abuse ; and (C) in subparagraph (B), by striking peer mentoring and inserting peer-to-peer support ; (4) in paragraph (5), by striking tribal and inserting Tribal ; (5) in paragraph (6)(A)— (A) in clause (iv), by striking ; and and inserting a semicolon; and (B) by adding at the end the following: (vi) a plan to sustain the activities carried out under the grant program, after the grant program has ended; and ; (6) in paragraph (8), by striking 2022 and inserting 2028 ; and (7) by amending paragraph (9) to read as follows: (9) Authorization of appropriations To carry out this subsection, there are authorized to be appropriated— (A) $10,000,000 for fiscal year 2026; (B) $12,000,000 for fiscal year 2027; (C) $13,000,000 for fiscal year 2028; (D) $14,000,000 for fiscal year 2029; and (E) $15,000,000 for fiscal year 2030. .
305CAREER Act
This section would rename section 7183 of the SUPPORT for Patients and Communities Act, currently titled the CAREER Act, to CAREER Act; Treatment, Recovery, and Workforce Support Grants, and would make a related wording clarification to subsection (b) about how the funding period is described. It would change how the highest-need areas eligible for grants are identified in subsection (c): instead of applying whatever rates are described in paragraph (2), the section would apply the average rates for calendar years 2018 through 2022 described in paragraph (2), and it would rewrite paragraph (2) to define those rates as the highest age-adjusted average rate of drug overdose deaths for calendar years 2018 through 2022, using Centers for Disease Control and Prevention data including provisional 2022 data if needed, the highest average unemployment rate for calendar years 2018 through 2022, using Bureau of Labor Statistics data, and the lowest average labor force participation rate for calendar years 2018 through 2022, using Bureau of Labor Statistics data. It would reorganize the allowable uses of grant funds in subsection (g) without changing the existing uses, and would add two new provisions: a grantee may use up to 5 percent of its grant funds to provide transportation for individuals to participate in a grant-supported activity, to or from a place of work, a place where the individual receives vocational education or job training, or a place where the individual receives services directly linked to substance use disorder treatment or recovery; and the Secretary may not require, or favor, an entity that plans to use grant funds for purposes other than those specified in the subsection. It would require that outcome reporting under subsection (i)(2) include employment and earnings outcomes, as described in the Workforce Innovation and Opportunity Act's standard performance metrics, for individuals with a substance use disorder who take part in grant-funded programs and activities. It would limit an existing reporting requirement in subsection (j)(1) to grants awarded before this Act's enactment, and it would replace a floating final-report deadline of two years after the preliminary report with a fixed deadline of September 30, 2030, along with a matching cross-reference update. It would also reauthorize the program's appropriations in subsection (k), raising the amount from $5,000,000 for each of fiscal years 2019 through 2023 to $12,000,000 for each of fiscal years 2026 through 2030. Separately, this section would reauthorize the related Recovery Housing Pilot Program under section 8071 of the SUPPORT for Patients and Communities Act, renaming the section CAREER Act; Recovery Housing Pilot Program and extending its authorization from 2023 through 2030. It would reset a 60-day action deadline in subsection (b)(1) to run from this Act's enactment rather than the original 2018 Act's enactment. It would update the data years used to identify high-need areas in subsection (b)(2)(B)(i) from calendar years 2013 through 2017 to calendar years 2018 through 2022 for unemployment and labor force participation rates, and would define the drug overdose death rate the same way as in section 7183: the highest age-adjusted average rate for calendar years 2018 through 2022, using Centers for Disease Control and Prevention data including provisional 2022 data if needed. It would also remove a 2-year time limit on a provision in subsection (f) of section 8071, so that provision, previously limited to the two years after the original 2018 enactment, would no longer be time-limited in that way. Finally, this section would update the SUPPORT for Patients and Communities Act's table of contents to match the renamed section 7183, the renamed Subtitle F of title VIII, and the renamed section 8071.
Show official text
305. CAREER Act (a) In general Section 7183 of the SUPPORT for Patients and Communities Act ( 42 U.S.C. 290ee–8 ) is amended— (1) in the section heading, by inserting ; TREATMENT, RECOVERY, AND WORKFORCE SUPPORT GRANTS after CAREER ACT ; (2) in subsection (b), by inserting each before for a period ; (3) in subsection (c)— (A) in paragraph (1), by striking the rates described in paragraph (2) and inserting the average rates for calendar years 2018 through 2022 described in paragraph (2) ; and (B) by amending paragraph (2) to read as follows: (2) Rates The rates described in this paragraph are the following: (A) The highest age-adjusted average rates of drug overdose deaths for calendar years 2018 through 2022 based on data from the Centers for Disease Control and Prevention, including, if necessary, provisional data for calendar year 2022. (B) The highest average rates of unemployment for calendar years 2018 through 2022 based on data provided by the Bureau of Labor Statistics. (C) The lowest average labor force participation rates for calendar years 2018 through 2022 based on data provided by the Bureau of Labor Statistics. ; (4) in subsection (g)— (A) in each of paragraphs (1) and (3), by redesignating subparagraphs (A) and (B) as clauses (i) and (ii), respectively, and adjusting the margins accordingly; (B) by redesignating paragraphs (1) through (3) as subparagraphs (A) through (C), respectively, and adjusting the margins accordingly; (C) in the matter preceding subparagraph (A) (as so redesignated), by striking An entity and inserting the following: (1) In general An entity ; and (D) by adding at the end the following: (2) Transportation services An entity receiving a grant under this section may use not more than 5 percent of the funds for providing transportation for individuals to participate in an activity supported by a grant under this section, which transportation shall be to or from a place of work or a place where the individual is receiving vocational education or job training services or receiving services directly linked to treatment of or recovery from a substance use disorder. (3) Limitation The Secretary may not require an entity to, or give priority to an entity that plans to, use the funds of a grant under this section for activities that are not specified in this subsection. ; (5) in subsection (i)(2), by inserting , which shall include employment and earnings outcomes described in subclauses (I) and (III) of section 116(b)(2)(A)(i) of the Workforce Innovation and Opportunity Act ( 29 U.S.C. 3141(b)(2)(A)(i) ) with respect to the participation of such individuals with a substance use disorder in programs and activities funded by the grant under this section after subsection (g) ; (6) in subsection (j)— (A) in paragraph (1), by inserting for grants awarded prior to the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025 after grant period under this section ; and (B) in paragraph (2)— (i) in the matter preceding subparagraph (A), by striking 2 years after submitting the preliminary report required under paragraph (1) and inserting September 30, 2030 ; and (ii) in subparagraph (A), by striking (g)(3) and inserting (g)(1)(C) ; and (7) in subsection (k), by striking $5,000,000 for each of fiscal years 2019 through 2023 and inserting $12,000,000 for each of fiscal years 2026 through 2030 . (b) Reauthorization of the CAREER Act; Recovery Housing Pilot Program (1) In general Section 8071 of the SUPPORT for Patients and Communities Act ( 42 U.S.C. 5301 note; Public Law 115–271 ) is amended— (A) by striking the section heading and inserting CAREER Act; Recovery Housing Pilot Program ; (B) in subsection (a), by striking through 2023 and inserting through 2030 ; (C) in subsection (b)— (i) in paragraph (1), by striking not later than 60 days after the date of enactment of this Act and inserting not later than 60 days after the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025 ; and (ii) in paragraph (2)(B)(i)— (I) in subclause (I)— (aa) by striking for calendar years 2013 through 2017 ; and (bb) by inserting for calendar years 2018 through 2022 after rates of unemployment ; (II) in subclause (II)— (aa) by striking for calendar years 2013 through 2017 ; and (bb) by inserting for calendar years 2018 through 2022 after participation rates ; and (III) by striking subclause (III) and inserting the following: (III) The highest age-adjusted average rates of drug overdose deaths for calendar years 2018 through 2022 based on data from the Centers for Disease Control and Prevention, including, if necessary, provisional data for calendar year 2022. ; and (D) in subsection (f), by striking For the 2-year period following the date of enactment of this Act, the and inserting The . (2) Conforming amendment Subtitle F of title VIII of the SUPPORT for Patients and Communities Act ( Public Law 115–271 ; 132 Stat. 4095) is amended by striking the subtitle heading and inserting the following: Subtitle F —CAREER Act; Recovery Housing Pilot Program . (c) Clerical amendments The table of contents in section 1(b) of the SUPPORT for Patients and Communities Act ( Public Law 115–271 ; 132 Stat. 3894) is amended— (1) by striking the item relating to section 7183 and inserting the following: Sec. 7183. CAREER Act; treatment, recovery, and workforce support grants. ; (2) by striking the item relating to subtitle F of title VIII and inserting the following: Subtitle F—CAREER Act; Recovery Housing Pilot Program ; and (3) by striking the item relating to section 8071 and inserting the following: Sec. 8071. CAREER Act; Recovery Housing Pilot Program. .
306Addressing economic and workforce impacts of the opioid crisis
This section would extend a program under section 8041(g)(1) of the SUPPORT for Patients and Communities Act, replacing a 2023 date with 2030.
Show official text
306. Addressing economic and workforce impacts of the opioid crisis Section 8041(g)(1) of the SUPPORT for Patients and Communities Act ( 29 U.S.C. 3225a(g)(1) ) is amended by striking 2023 and inserting 2030 . IV Miscellaneous matters
401Delivery of a controlled substance by a pharmacy to a prescribing practitioner
This section would replace one of the conditions under which a pharmacy may deliver a controlled substance directly to a prescribing practitioner, rather than to the patient, under section 309A(a) of the Controlled Substances Act. Under the new condition, the controlled substance must be a schedule III, IV, or V drug that will be administered either by injection or implantation for maintenance or detoxification treatment, or under a risk evaluation and mitigation strategy required by section 505-1 of the Federal Food, Drug, and Cosmetic Act that includes elements to assure safe use of the drug, including a requirement that a health care provider monitor the patient after the drug is administered.
Show official text
401. Delivery of a controlled substance by a pharmacy to a prescribing practitioner Section 309A(a) of the Controlled Substances Act ( 21 U.S.C. 829a(a) ) is amended by striking paragraph (2) and inserting the following: (2) the controlled substance is a drug in schedule III, IV, or V to be administered— (A) by injection or implantation for the purpose of maintenance or detoxification treatment; or (B) subject to a risk evaluation and mitigation strategy pursuant to section 505–1 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355–1 ) that includes elements to assure safe use of the drug described in subsection (f)(3)(E) of such section, including a requirement for post-administration monitoring by a health care provider; .
402Required training for prescribers of controlled substances
This section would fix a drafting error in section 303 of the Controlled Substances Act, where two different subsections had both been labeled subsection (l); the second one would be redesignated as subsection (m). It would then broaden the list of professional organizations, accrediting bodies, and curricula whose training satisfies the controlled substance prescriber training requirement in that redesignated subsection (m)(1). For physicians, dentists, and related prescribers, it would add the American Academy of Family Physicians, the American Podiatric Medical Association, the Academy of General Dentistry, and the American Optometric Association to the list of organizations whose training counts, add the Council on Podiatric Medical Education as an additional qualifying accrediting body, and add podiatric medicine as a covered profession and curriculum alongside allopathic, osteopathic, and dental medicine. For pharmacists, nurses, and related prescribers, it would add the American Pharmacists Association, the Accreditation Council on Pharmacy Education, the American Psychiatric Nurses Association, the American Academy of Nursing, and the American Academy of Family Physicians to the list of qualifying organizations, and add accredited schools of pharmacy to the list of qualifying schools. This section states that these changes take effect as if they had been enacted on December 29, 2022.
Show official text
402. Required training for prescribers of controlled substances (a) In general Section 303 of the Controlled Substances Act ( 21 U.S.C. 823 ) is amended— (1) by redesignating the second subsection designated as subsection (l) as subsection (m); and (2) in subsection (m)(1), as so redesignated— (A) in subparagraph (A)— (i) in clause (iv)— (I) in subclause (I)— (aa) by inserting the American Academy of Family Physicians, the American Podiatric Medical Association, the Academy of General Dentistry, the American Optometric Association, before or any other organization ; (bb) by striking or the Commission and inserting , the Commission ; and (cc) by inserting , or the Council on Podiatric Medical Education before the semicolon at the end; and (II) in subclause (III), by inserting or the American Academy of Family Physicians after Association ; and (ii) in clause (v), in the matter preceding subclause (I)— (I) by striking osteopathic medicine, dental surgery and inserting osteopathic medicine, podiatric medicine, dental surgery ; and (II) by striking or dental medicine curriculum and inserting or dental or podiatric medicine curriculum ; and (B) in subparagraph (B)— (i) in clause (i)— (I) by inserting the American Pharmacists Association, the Accreditation Council on Pharmacy Education, the American Psychiatric Nurses Association, the American Academy of Nursing, the American Academy of Family Physicians, before or any other organization ; and (II) by inserting , the American Academy of Family Physicians, before or the Accreditation Council ; and (ii) in clause (ii)— (I) by striking or accredited school and inserting , an accredited school ; and (II) by inserting , or an accredited school of pharmacy before in the United States . (b) Effective date The amendment made by subsection (a) shall take effect as if enacted on December 29, 2022.
Where it is
In the House.